- Home
- ICLR vs GGB Comparison
ICLR vs GGB Comparison
Compare ICLR & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | GGB |
|---|---|---|
| Founded | 1990 | 1901 |
| Country | Ireland | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.4B |
| IPO Year | 2001 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ICLR | GGB |
|---|---|---|
| Price | $116.30 | $4.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $178.62 | $5.38 |
| AVG Volume (30 Days) | 1.3M | ★ 17.6M |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.59 |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ $12.91 | $13.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $2.61 |
| 52 Week High | $211.00 | $4.98 |
Technical Indicators
Market Signals| Indicator | ICLR | GGB |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 60.84 |
| Support Level | $99.11 | $4.13 |
| Resistance Level | $121.03 | $4.98 |
| Average True Range (ATR) | 6.15 | 0.15 |
| MACD | -0.64 | -0.03 |
| Stochastic Oscillator | 32.51 | 51.02 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Segment; North America Segment; South America Segment as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.